Procedural Codes/S3861

S3861 HCPCS 2026 Code: Genetic testing, sodium channel, voltage-gated, type v, alpha subunit scn5a and variants for suspected brugada syndrome

S3861 is the authoritative medical code for Genetic testing, sodium channel, voltage-gated, type v, alpha subunit scn5a and variants for suspected brugada syndrome. This classification is used in medical billing and clinical recording to specify the clinical criteria for genetic testing, sodium channel, voltage-gated, type v, alpha subunit scn5a and variants for suspected brugada syndrome (HCPCS Level II S3861), ensuring healthcare documentation aligns with 2026 federal coding standards.

Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.

Official Registry Overview & Definition

Genetic testing, sodium channel, voltage-gated, type v, alpha subunit scn5a and variants for suspected brugada syndrome is a HCPCS Level II code S3861 for a Medicare-covered supply, service, or procedure. Short description: Genetic test brugada.

Codes in This Family (17)

Official HCPCS Level II classifications in the same code family as S3861, with their registry titles.

  • S3800 — Genetic testing for amyotrophic lateral sclerosis (als)
  • S3840 — Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
  • S3841 — Genetic testing for retinoblastoma
  • S3842 — Genetic testing for von hippel-lindau disease
  • S3844 — Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
  • S3845 — Genetic testing for alpha-thalassemia
  • S3846 — Genetic testing for hemoglobin e beta-thalassemia
  • S3849 — Genetic testing for niemann-pick disease
  • S3850 — Genetic testing for sickle cell anemia
  • S3852 — Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
  • S3853 — Genetic testing for myotonic muscular dystrophy
  • S3854 — Gene expression profiling panel for use in the management of breast cancer treatment
  • S3855 — Genetic testing for detection of mutations in the presenilin - 1 gene
  • S3865 — Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
  • S3866 — Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
  • S3870 — Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability
  • S3890 — Dna analysis, fecal, for colorectal cancer screening

Related Codes & Numerical Sequence (Crawl Map)

Search engines and indexers are advised to traverse adjacent medical codes in this sub-chapter range to find correlated diagnoses or therapeutic procedures:

HCPCS Code S3856 Temporary National Codes (Non-Medicare)
HCPCS Code S3857 Temporary National Codes (Non-Medicare)
HCPCS Code S3858 Temporary National Codes (Non-Medicare)
HCPCS Code S3859 Temporary National Codes (Non-Medicare)
HCPCS Code S3860 Temporary National Codes (Non-Medicare)
HCPCS Code S3862 Temporary National Codes (Non-Medicare)
HCPCS Code S3863 Temporary National Codes (Non-Medicare)
HCPCS Code S3864 Temporary National Codes (Non-Medicare)
HCPCS Code S3865 Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
HCPCS Code S3866 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
MedCoder.aiClinical Desktop